首页> 外文期刊>Neurosurgery >Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system.
【24h】

Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system.

机译:血管内修复性神经外科:神经系统的分子和细胞疗法的新概念。

获取原文
获取原文并翻译 | 示例
           

摘要

THE AMALGAM OF molecular biology and neurosurgery offers immense promise for neurorestoration and the management of neurodegenerative deficiencies, developmental disorders, neoplasms, stroke, and trauma. This article summarizes present strategies for and impediments to gene therapy and stem cell therapy of the central nervous system and advances the concept of a potential new approach, namely endovascular restorative neurosurgery. The objectives of gene transfer to the central nervous system are efficient transfection of host cells, selective sustained expression of the transgene, and lack of toxicity or immune excitation. The requisite elements of this process are the identification of candidate diseases, the construction of vehicles for gene transfer, regulated expression, and physical delivery. In the selection of target disorders, the underlying genetic events to be overcome, as well as their spatial and temporal distributions, must be considered. These factors determine the requirements for the physical dispersal of the transgene, the duration of transgene expression, and the quantity of transgene product needed to abrogate the disease phenotype. Vehicles for conveying the transgene to the central nervous system include viral vectors (retroviruses, lentiviruses, adenoviruses, adeno-associated viruses, and herpes simplex virus), liposomes, and genetically engineered cells, including neural stem cells. Delivery of the transgene into the brain presents several challenges, including limited and potentially risky access through the cranium, sensitivity to volumetric changes, restricted diffusion, and the blood-brain barrier. Genetic or cellular therapeutic agents may be injected directly into the brain parenchyma (via stereotaxy or craniotomy), into the cerebrospinal fluid (in the ventricles or cisterns), or into the bloodstream (intravenously or intra-arterially). The advantages of the endovascular route include the potential for widespread distribution, the ability to deliver large volumes, limited perturbation of neural tissue, and the feasibility of repeated administration.
机译:分子生物学和神经外科手术的融合为神经修复和神经退行性缺陷,发育障碍,肿瘤,中风和创伤的治疗提供了广阔的前景。本文总结了中枢神经系统基因治疗和干细胞治疗的现有策略和障碍,并提出了一种潜在的新方法的概念,即血管内修复性神经外科。基因转移到中枢神经系统的目的是宿主细胞的有效转染,转基因的选择性持续表达以及缺乏毒性或免疫激发作用。该过程的必要要素是识别候选疾病,构建基因转移,调节表达和物理传递的载体。在选择目标疾病时,必须考虑要克服的潜在遗传事件及其时空分布。这些因素决定了转基因的物理分散,转基因表达的持续时间以及消除疾病表型所需的转基因产物的数量。用于将转基因传递至中枢神经系统的载体包括病毒载体(逆转录病毒,慢病毒,腺病毒,腺相关病毒和单纯疱疹病毒),脂质体和基因工程细胞,包括神经干细胞。转基因进入大脑的过程面临着许多挑战,包括通过颅骨的访问受限和潜在风险,对体积变化的敏感性,扩散受限以及血脑屏障。遗传或细胞治疗剂可直接注射到脑实质中(通过立体定位或开颅手术),脑脊髓液(在心室或水箱中)或血液(静脉内或动脉内)注射。血管内途径的优点包括广泛分布的潜力,递送大容量的能力,有限的神​​经组织扰动以及重复给药的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号